PharVision Advisers LLC purchased a new position in Bain Capital Specialty Finance, Inc. (NYSE:BCSF - Free Report) during the 1st quarter, according to its most recent disclosure with the SEC. The fund purchased 18,929 shares of the company's stock, valued at approximately $314,000.
Several other hedge funds and other institutional investors have also modified their holdings of BCSF. Quarry LP acquired a new position in Bain Capital Specialty Finance during the 1st quarter valued at $100,000. Lazard Asset Management LLC lifted its stake in Bain Capital Specialty Finance by 14.5% during the fourth quarter. Lazard Asset Management LLC now owns 9,361 shares of the company's stock worth $164,000 after purchasing an additional 1,189 shares during the period. MQS Management LLC bought a new stake in Bain Capital Specialty Finance in the first quarter valued at $176,000. Jump Financial LLC bought a new stake in shares of Bain Capital Specialty Finance in the 1st quarter worth about $200,000. Finally, Mutual Advisors LLC increased its position in shares of Bain Capital Specialty Finance by 5.1% during the 1st quarter. Mutual Advisors LLC now owns 15,762 shares of the company's stock worth $245,000 after purchasing an additional 768 shares in the last quarter.
Analyst Upgrades and Downgrades
Separately, Zacks Research upgraded Bain Capital Specialty Finance from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 19th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of "Buy" and an average target price of $16.50.
Get Our Latest Stock Report on BCSF
Bain Capital Specialty Finance Price Performance
Shares of NYSE:BCSF traded down $0.05 during trading on Tuesday, hitting $15.61. 221,856 shares of the company were exchanged, compared to its average volume of 221,406. The company has a quick ratio of 3.63, a current ratio of 3.63 and a debt-to-equity ratio of 1.37. Bain Capital Specialty Finance, Inc. has a 1-year low of $13.20 and a 1-year high of $19.21. The company has a market capitalization of $1.01 billion, a P/E ratio of 9.40 and a beta of 0.83. The business's 50 day moving average is $15.33 and its 200-day moving average is $15.63.
Bain Capital Specialty Finance (NYSE:BCSF - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.47 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.43 by $0.04. The business had revenue of $70.97 million during the quarter, compared to analysts' expectations of $67.88 million. Bain Capital Specialty Finance had a return on equity of 11.41% and a net margin of 37.90%. Equities analysts forecast that Bain Capital Specialty Finance, Inc. will post 2.06 earnings per share for the current year.
Bain Capital Specialty Finance Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be given a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 10.8%. The ex-dividend date is Tuesday, September 16th. Bain Capital Specialty Finance's dividend payout ratio (DPR) is 101.20%.
Bain Capital Specialty Finance Company Profile
(
Free Report)
Bain Capital Specialty Finance, Inc is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt.
Further Reading

Before you consider Bain Capital Specialty Finance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bain Capital Specialty Finance wasn't on the list.
While Bain Capital Specialty Finance currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.